Delivery Order SPE2DB22D3501-SPE2DB25FWV34
Award Date 8/12/25
Potential Completion Date 9/3/25
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,114.18 to AmerisourceBergen Drug Corp for Praxbind (idarucizumab) 5G dose in 2.5G/50mL vials on December 18, 2025, with completion scheduled for January 12, 2026. Praxbind is a reversal agent used in emergency medical settings to counteract the anticoagulant effects of dabigatran, making it a critical pharmaceutical for military and veteran healthcare systems. This is a firm fixed-price delivery order with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Praxbind (idarucizumab) 5G Dose in 2x 2.5G/50ML vials, with a contract ceiling value of $3,216.70 and an ultimate completion date of October 20, 2025. This is a firm fixed price, non-set-aside delivery order that represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through...
- The Defense Logistics Agency awarded a delivery order valued at $6,433.40 to AmerisourceBergen Drug Corp for the supply of Praxbind (idarucizumab) 5G dose in 2x 2.5G/50ML vials, with a firm fixed-price contract type and an ultimate completion date of October 1, 2025. This award, issued on September 10, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Praxbind (idarucizumab) injection. The $2,881.90 firm-fixed price delivery order falls under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PRAXBIND 5G DOSE (2X 2.5G/50ML) 50ML, a medication, with a ceiling value of $3,216.70. The contract is a firm fixed-price, non-set-aside award with a performance period extending until May 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of PRAXBIND 5G DOSE (2X 2.5G/50ML) 50ML medical products. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $5,763.80 and an ultimate completion date of October 11, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds several Indefinite Delivery...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $2,852.42 firm fixed price delivery order by the Defense Logistics Agency to supply 4561453872 PRAXBIND 5G DOSE(2X 2.5G/50ML) 50ML pharmaceutical products. Performance will take place in Conshohocken, Pennsylvania, spanning from July 10, 2023 through July 31, 2023. The award is issued against an unidentified indefinite-delivery/indefinite-quantity multiple award contract vehicle managed by the...
- The U.S. Defense Logistics Agency (DLA) awarded a $37,269.81 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, with a completion date of September 4, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Pradaxa 150 mg capsules (60-count units) with a ceiling value of $1,960.47. This firm fixed price delivery order, which has an ultimate completion date of August 4, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The Delivery Order, valued at $1,843.61, is for the supply of 4,564,377,077 units of the pharmaceutical drug Pradaxa 150 mg capsules. The contract has a firm fixed price and an ultimate completion date of April 24, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly...